Skip to main content
OpenTrials

Clinical trial condition

Infections, Streptococcal

Explore clinical trials studying Infections, Streptococcal. Study availability and eligibility vary by location and protocol.

58 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Streptococcal trial results

Completed

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

NCT00307541

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Marbach, Baden-Wurttemberg, Germany
  • GSK Investigational Site Nördlingen, Bavaria, Germany
  • GSK Investigational Site Tutzing, Bavaria, Germany
View all 32 locations
View Trial Details
Completed

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

NCT01545375

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • GSK Investigational Site Chinle, Arizona, United States
  • GSK Investigational Site Fort Defiance, Arizona, United States
  • GSK Investigational Site Whiteriver, Arizona, United States
  • GSK Investigational Site Gallup, New Mexico, United States
View Trial Details
Completed

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

NCT02270944

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • GSK Investigational Site Redding, California, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Stevensville, Michigan, United States
View Trial Details
Completed

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children

NCT01027845

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Hiroshima, Japan
  • GSK Investigational Site Hiroshima, Japan
View all 16 locations
View Trial Details
Completed

Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.

NCT02838407

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • GSK Investigational Site Barakaldo (Vizcaya), Spain
  • GSK Investigational Site Barcelona, Spain
  • GSK Investigational Site Madrid, Spain
  • GSK Investigational Site Madrid, Spain
View Trial Details
Completed

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

NCT01616459

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Benešov, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Domažlice, Czechia
  • GSK Investigational Site Jindřichův Hradec, Czechia
View all 42 locations
View Trial Details
Completed

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

NCT00466947

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Community-Acquired Infections, +14 more
Locations
  • GSK Investigational Site Godoy Cruz, Mendoza Province, Argentina
  • GSK Investigational Site Las Heras, Mendoza Province, Argentina
  • GSK Investigational Site Lujan de Cuyo, Mendoza Province, Argentina
  • GSK Investigational Site Villa Nueva, Mendoza Province, Argentina
View all 22 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection

NCT01746108

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Warsaw, Poland
  • GSK Investigational Site Wroclaw, Poland
  • GSK Investigational Site Barnaul, Russia
View Trial Details

Related conditions